Roche, Harvard, and BioBay Cooperate on Asia's First Bio-Med Incubator Project
The signing ceremony of Roche, Harvard, BioBay & Wen Associates Incubator project and Nimbus InnoWorks opening ceremony were held at SIP Dushu Lake Hotel on the morning of October 24. Dr. Michal Preminger, Executive Director of the Harvard Medical School Office at Harvard University's Office of Technology Development, Dan Zabrowski, head of Roche Partnering and member of the Enlarged Corporate Executive Committee, and Ma Minglong, Standing Committee Member of CPC Suzhou Municipal Committee and Secretary of SIP CPC Working Committee, attended the ceremony.
Nimbus InnoWorks is a company engaged mainly in identifying, selecting, introducing, and cultivating early-stage products in the field of bio-science.
The cooperation project is the only incubator in bio-tech sector and the first one jointly initiated by an incubation base, a pharmaceutical leader, and a prestigious research institution in Asia. Its initial mission is to develop autophagy inhibitor for cancer treatment.
As a well-established college in the world, two-century-old Harvard Medical School stands out with unique education philosophy, effective management, and rich resources, and has produced a group of top talents in the world's bio-science community. Dr. Michal Preminger said the project served as a bridge connecting Harvard, Roche, and Biobay.
Founded in 1896 and now a global leader in pharmaceutical market, Roche started business in China in 1926 and opened its Chinese R&D center in 2007, creating a complete industrial chain of research, development, production, and marketing. As a leading innovator in the field, Roche relies on the innovation incubating network in the world. Most of its incubators are based in Boston, and Harvard University is one of its important partners. In Israel, Roche cooperates with University of Jerusalem and incubated six bio-med startups. Local government believed that the cooperation project with the giants in the field would definitely infuse new energy into the local bio-med sector.
October 25, 2011